Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir
- 124 Downloads
Tenofovir-related tubule damage characterized by Fanconi syndrome, renal insufficiency and nephrogenic diabetes insipidus has been reported in the adult HIV-infected population. To our knowledge there has been no reported case of such complications in the pediatric population. We report the case of a 12-year-old perinatally HIV-infected African–American girl who developed nephrogenic diabetes insipidus, renal insufficiency and Fanconi-like syndrome while taking tenofovir (Viread) in combination with lopinavir–ritonavir (Kaletra) and didanosine (Videx).
KeywordsFanconi syndrome Renal insufficiency Nephrogenic diabetes insipidus HIV Tenofovir
- 1.Karras A, Lafaurie M, Furco A, Bourgarit A, Droz D, Sereni D, Legendre C, Martinez F, Molina JM (2003) Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. Clin Infect Dis 36:1070–1073PubMedCrossRefGoogle Scholar
- 2.Rollot F, Nazal E, Chauvelot-Moachon L, Kelaidi C, Daniel N, Saba M, Abad S, Blanche P (2003) Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir–ritonavir–didanosine. Clin Infect Dis 37:174–176CrossRefGoogle Scholar
- 6.US Food and Drug Administration (2001) FDA report: background package for NDA 21-356:Viread (tenofovir disoproxil fumarate)Google Scholar